Decal

Quick links to important sections

Decal

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Decal

Quick Facts: Decal Identity

Property Description
Active ingredients Calcium Phosphate, Colecalciferol (Vitamin D3)
Form Tablet (often chewable), Oral solution (Syrup)
Pharmacological class Specific Mineral and Vitamin D Preparation
Common purpose Nutritional supplement to support bone health
Origin Combination product of a mineral derivative and a vitamin analog

Identity and Classification: A Mineral-Vitamin Combination Product

Decal is classified as an oral combination product that falls within the pharmacological class of Specific Mineral and Vitamin D Preparation. This classification reflects its dual nature, containing both a mineral and a vitamin analog, designed to simultaneously address deficiencies in both factors. The product is primarily utilized as an oral nutritional supplement to support the body's mineral balance and bone structure.

Decal's identity as a combination product is critical, distinguishing it from single-ingredient supplements and offering a streamlined therapeutic approach. It is commonly available as an over-the-counter (OTC) product tailored for nutritional support, often targeting postmenopausal women and the elderly people who are at elevated risk of deficiencies.


Decal's Composition: Calcium Phosphate and Colecalciferol

The active ingredients in Decal are Calcium Phosphate and Colecalciferol (Vitamin D3). Calcium Phosphate serves as the source of the elemental calcium and phosphate ions, while Colecalciferol is the fat-soluble vitamin and prohormone component. The medicine is supplied for oral administration in various pharmaceutical preparations, including the solid tablet (often chewable) and the liquid oral solution (syrup).

The selection of Calcium Phosphate is intentional, providing not only elemental calcium but also phosphate ions, which are integral to bone tissue formation. This unique composition enhances the overall approach to bone mineralisation compared to simpler calcium-only preparations.


What is the General Purpose of Taking Decal?

The general purpose of Decal is to support robust calcium homeostasis and bone formation by ensuring the adequate supply and effective utilization of these critical elements. The product functions as a fundamental replacement therapy against deficiencies. The combined action aids in skeletal maintenance, with Colecalciferol optimizing the absorption of the calcium and phosphorus provided. This mechanism is essential for maintaining the structural integrity of the skeleton and supporting vital nerve and muscle function which rely on stable mineral balance.

Regulatory References

  1. Cholecalciferol - StatPearls - NCBI Bookshelf

What side effects are possible with Decal?

Possible Side Effects and Safety Information for Decal

This section describes the officially documented adverse reactions and safety-related restrictions for Decal, as classified by government regulatory authorities.

Adverse Reaction Classification

Side effects are classified by their frequency of occurrence in clinical studies and grouped by the affected System-Organ Class (SOC). The frequency categories used in regulatory documents are:

  • Very Common: Occurs in 1 in 10 patients or more (ge 1/10).
  • Common: Occurs in 1 in 100 to less than 1 in 10 patients (ge 1/100 to < 1/10).
  • Uncommon: Occurs in 1 in 1,000 to less than 1 in 100 patients (ge 1/1,000 to < 1/100).
  • Rare: Occurs in 1 in 10,000 to less than 1 in 1,000 patients (ge 1/10,000 to < 1/1,000).
  • Very Rare: Occurs in less than 1 in 10,000 patients (< 1/10,000).
  • Not Known: Frequency cannot be estimated from available data.

Serious adverse reactions (those that are life-threatening, fatal, or result in major disability) are specifically highlighted in regulatory documents under Warnings and Precautions.

Safety-Related Restrictions

Contraindications define conditions or situations under which Decal must not be used, such as a known hypersensitivity to the active substance or excipients.

Warnings and Precautions detail specific risks requiring caution or monitoring. These may include the need for baseline or periodic laboratory testing (e.g., monitoring liver function) or specific safety notes regarding potential effects on the nervous system.

Population-Specific Safety Notes

The official label includes specific regulatory statements regarding the use of Decal in special populations. These notes address documented safety differences or restrictions for use during pregnancy, lactation, and in patients with established renal (kidney) or hepatic (liver) impairment. Any explicitly stated dose- or exposure-related patterns that affect the incidence or severity of adverse reactions are also documented here.

Overdose and Emergency Response

Decal overdose is officially defined by excessive exposure to its components, leading to hypercalcemia and manifestations of hypervitaminosis D. Clinical signs documented in regulatory sources include initial manifestations such as anorexia, nausea, vomiting, polyuria, polydipsia, muscle weakness, and somnolence.

Category Official Regulatory Statements
Severe Outcomes Risk of renal failure, cardiac arrhythmia, coma, and soft tissue calcinosis is documented with protracted toxicity.
Emergency Action Seek immediate medical attention if overdose is suspected; contact emergency services immediately is mandated.
Supportive Management Treatment is described as symptomatic and supportive, including immediate cessation of the product, correcting dehydration, and, in acute cases, gastric lavage or activated charcoal. No specific antidote is known.
Monitoring Hospital monitoring is required, specifically including ECG monitoring and close observation of serum calcium levels.

The official labeling notes that patients with impaired renal function have an increased susceptibility to toxic effects, and special consideration is required for paediatric patients due to heightened sensitivity. The regulatory profile explicitly uses these severe outcomes and documented clinical presentations to trigger the mandatory requirement to seek urgent medical help.

Therapeutic Uses of Decal

What Decal Treats: Main Uses and Benefits

Decal (calcium and Vitamin D) is applied across domains where additional symptomatic support is needed, particularly to manage discomfort and functional strain arising from mineral deficits. Vitamin D may assist in managing symptoms related to hypocalcemic tetany—a condition characterized by involuntary muscle contractions. The medication supports the patient during difficult episodes by easing distress when symptoms become noticeable.

It is commonly used across conditions characterized by episodic or fluctuating manifestations such as osteoporosis, osteomalacia, and rickets. It also helps address groups of symptoms that may become intense or disruptive, including muscle cramping and overall discomfort related to bone mineral loss.

Clinical Context and Benefit

The product is often used during phases when symptoms intensify and supportive relief is needed. The product contributes to improved day-to-day comfort during symptomatic periods. It is relevant when short-term symptomatic assistance is needed to help maintain a sense of stability when symptoms are more noticeable.

Quick Fact: Support for Symptoms related to systemic imbalance

Eligibility and Restrictions for Use

Who Can and Cannot Use Decal?

The official eligibility for Decal (Calcium Phosphate and Colecalciferol) is strictly defined by government regulatory documents, focusing on patient mineral balance and the status of kidney function. Use is determined by the avoidance of metabolic risk rather than therapeutic benefit.

Absolute Prohibitions (Contraindications)

Decal is absolutely contraindicated for use in individuals who exhibit pre-existing mineral overload. This includes patients diagnosed with Hypercalcemia (high calcium in the blood), Hypercalciuria (high calcium in the urine), or Hypervitaminosis D (excessive Vitamin D levels). Furthermore, the medicine is prohibited for those with Severe Renal Impairment (severe kidney failure) and a history of calcium-containing Nephrolithiasis (kidney stones).

Conditional Eligibility and Restrictions

Use is generally permitted for Adults and the Elderly population with documented deficiency. However, it is Not Recommended for the Pediatric Population (children under 12 years of age). During Pregnancy and Lactation, use is conditional on avoiding overdose and requires close supervision. Patients with conditions that affect calcium metabolism, such as Sarcoidosis or those with Mild to Moderate Renal Impairment, are restricted to use only with specific regulatory caution and monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Decal (Calcium Phosphate and Colecalciferol) interactions are officially documented across several regulatory categories, primarily concerning additive effects on calcium levels or absorption interference.

Documented Pharmacodynamic and Contraindicated Interactions

Co-administration with metabolites or analogues of Vitamin D (e.g., Calcitriol) must be formally avoided due to the severe, documented risk of hypercalcemia. Concomitant use with Thiazide Diuretics (e.g., Hydrochlorothiazide) is a clinically significant interaction that may lead to hypercalcemia as these agents reduce urinary calcium excretion. The effects of Cardiac Glycosides (e.g., Digoxin) may be accentuated, increasing the risk of cardiac arrhythmias due to elevated serum calcium concentrations.

Pharmacokinetic and Timing Restrictions

  • Enzyme Interaction: Anti-convulsants (e.g., Phenytoin) and Rifampicin are documented to reduce Colecalciferol effectiveness via hepatic enzyme induction or inhibited metabolic activation.
  • Chelation: The calcium component significantly decreases the absorption of Tetracycline and Quinolone Antibiotics (e.g., Ciprofloxacin). This interaction requires that the medicines be separated by at least two hours.
  • Absorption: Agents that cause fat malabsorption (e.g., Cholestyramine) are documented to reduce the absorption of the fat-soluble Colecalciferol.

Food and Population Notes

Interaction occurs with foods high in oxalic acid (e.g., spinach) or phytic acid (e.g., bran), which are documented to decrease calcium absorption. Official notes also specify that Colecalciferol is not metabolized normally in patients with severe renal insufficiency.

Mechanism of Action

Decal functions as a high-affinity antagonist at central dopamine D2 receptors (D2). The primary biological target for Decal is within the mesolimbic and mesocortical dopaminergic pathways in the central nervous system. Its molecular interaction involves competitive binding at the orthosteric site of the D2 receptor, which prevents the endogenous neurotransmitter, dopamine, from binding and initiating signaling.

This intracellular pathway modification results in a sustained reduction of adenylyl cyclase activity, which decreases the production of the second messenger cyclic adenosine monophosphate (cAMP). The downstream cascade involves the modulation of cAMP-dependent protein kinase A (PKA) activity, ultimately altering the phosphorylation state and functional activity of key effector proteins and gene expression linked to dopaminergic neurotransmission.

At the system-level, the physiological consequence is the attenuation of excessive postsynaptic dopaminergic signaling. This sustained antagonism modulates neuronal activity in circuits involved in executive function and perception, resulting in a stabilizing system-level physiological modulation of the central nervous system.

Dosage and Administration Information

How Decal is Used: Standard Administration

Decal, a combination of Calcium Phosphate and Colecalciferol (Vitamin D3), is administered via the oral route for available dosage forms, which include tablets, chewable tablets, and oral solutions. The usage pattern involves specific dosing schedules, frequency, and administration conditions.

Dosing and Frequency Patterns

The standard approach involves either a long-term maintenance regimen or a short-term, high-strength course to correct a severe deficiency. For maintenance, daily doses range from 500 mg to 1250 mg of elemental calcium combined with 200 IU to 1000 IU of Vitamin D3. This regimen is typically taken once daily or in divided doses. Total daily calcium doses exceeding approximately 600 mg are often divided and spaced throughout the day to optimize mineral absorption.

For short-term correction protocols, Colecalciferol may be administered at high strengths, such as 50,000 IU taken once weekly for a limited course, typically 6 to 12 weeks.

Administration Requirements

Proper administration is conditioned by the dosage form and food intake. The medicine is generally taken with food or a meal, which enhances the absorption of the fat-soluble Vitamin D component. Specific handling is required for different forms:

  • Chewable tablets must be chewed thoroughly before swallowing.
  • Oral solutions must be measured precisely using the provided device.
  • If a dose is missed, it is taken when remembered, but if it is near the time for the next dose, the missed dose is skipped to avoid taking a double quantity.

Dosage selection for specific groups, such as older adults, is typically cautious, generally starting at the lower end of the maintenance range due to potential age-related functional decline.

Recent Clinical Evidence

Research Exploring Outcomes Related to Bone Structure and Osteoporosis Risk

Research has primarily focused on the combination product in conditions characterized by functional limitations, exploring outcomes related to bone structure maintenance and fracture risk. This was studied for several years using large Randomized Controlled Trials (RCTs) and meta-analyses, primarily examining older adults and postmenopausal women.

The trials recorded outcomes that included changes in Bone Mineral Density (BMD) and observing the incidence of new fractures over time. Findings have described patterns observed in the studies regarding fracture frequency. However, the findings were mixed when comparing results among healthy, community-dwelling older adults to those who were institutionalized and frail.

What remains uncertain is whether these products apply similarly to all segments of the population; the results apply only to the populations studied. There is a significant degree of heterogeneity across studies, meaning the specific doses, duration, and participants' starting levels of calcium and vitamin D varied widely. Furthermore, the evidence related to preventing vertebral (spinal) fractures is limited.


Research Exploring Changes in Mineral and Vitamin D Status

Research for this purpose is drawn from a relatively coherent body of evidence. This area was evaluated in RCTs and high-quality observational studies. Researchers monitored changes in essential biomarkers over a short- to intermediate-term period, typically six months to two years.

The primary outcomes studied were changes in the blood concentration of serum 25-hydroxyvitamin D [25(OH)D] and shifts in Parathyroid Hormone (PTH) levels. The studies describe patterns in the measured levels of these biomarkers, which were reported to stabilize or rise in participants who were deficient at the start of the study.

Follow-up durations were limited for many of these biochemical analyses, meaning long-term effects are not fully established regarding sustained normalization for many years. Additionally, these studies tend to be highly focused on specific groups, such as the institutionalized elderly.

Key Studies & References

  1. Association Between Vitamin D Supplementation and Fall Prevention
  2. Cholecalciferol - StatPearls (NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Decal (FAQ)

Q: What is Decal used for, besides the main thing it treats?

Regulatory documents state that Decal, a combination of Calcium and Vitamin D3, is used as a nutritional supplement to address deficiencies and support overall bone health. It may also be used for other specific, documented conditions related to these deficiencies as determined by a healthcare professional.

Q: Is Decal the same kind of medicine as [similar well-known drug name]?

Official product information classifies Decal as a Specific Mineral and Vitamin D Preparation. This means it is a combination product, which places it in a different pharmacological class than single-ingredient supplements. Its core function is to supplement two factors integral to bone health.

Q: Is it normal to feel a bit nauseous when first starting Decal?

Nausea, stomach upset, and vomiting are commonly reported side effects associated with products containing high concentrations of calcium and Vitamin D. These effects are generally related to the gastrointestinal system, and official documents categorize them as common.

Q: What are the long-term effects of taking Decal?

Taking this medicine for a long period of time carries a risk of developing high levels of calcium in the body, a condition known as hypercalcemia. The potential long-term risk relates to calcium accumulation, which regulatory warnings state may affect organs such as the kidneys and heart in rare cases. Regulatory warnings indicate that monitoring blood calcium levels is advised for patients receiving long-term treatment.

Q: Is Decal safe to use for teenagers or children?

Official regulatory documents indicate that use in children and adolescents requires professional guidance, as dosing must be individualized based on age, severity of deficiency, and other risk factors. Regulatory documents indicate that careful monitoring is advised for younger patients, as inappropriate amounts could lead to toxicity.

Q: What makes Decal different from other medicines that treat the same condition?

Decal is a combination product that delivers both elemental calcium and Colecalciferol (Vitamin D3) simultaneously. This dual composition is intended to address deficiencies in both the mineral and vitamin factors required for bone mineralization.

Q: Do I need to get blood tests done regularly while taking Decal?

Official documentation indicates that periodic laboratory tests are typically advised for patients on long-term treatment or high doses. Patients must have their serum calcium levels (blood calcium) and sometimes urine calcium excretion monitored regularly to avoid the development of high calcium levels.

Q: Why do some people say Decal didn't work for them?

Official research and clinical trials have noted that outcomes can be mixed among different patient populations, with a significant degree of heterogeneity (variability) observed. This means the results apply primarily to the specific groups studied, which can lead to variability in the observed outcomes across different patient groups.

Q: Does the time of day matter when taking Decal?

Official guidelines generally instruct that the medicine should be taken with food or a meal, as this enhances the absorption of the fat-soluble Vitamin D component. The specific time of day (morning or night) is typically not detailed in the official administration documents.

Q: Are allergic reactions to Decal common?

Allergic reactions, classified as hypersensitivity to the active ingredients or other components, are a known risk and are listed as a contraindication (a condition where the medicine should not be used). For individuals with a known history of hypersensitivity, official product information indicates the medicine should not be used.

Q: What are the most commonly reported side effects of Decal?

According to regulatory adverse reaction summaries, the most common side effects involve the gastrointestinal system. These frequently include symptoms like constipation, gas, or stomach discomfort. High calcium levels in the blood or urine are listed as uncommon side effects.

Q: Can Decal be split or crushed if I have trouble swallowing pills?

The official guidelines require certain forms, such as chewable tablets, to be chewed completely before swallowing. For regular tablets, official instructions state to swallow them whole with water. Unless the product label or a health professional specifically advises otherwise, non-chewable tablets are intended to be swallowed whole.

Q: Does Decal interact with supplements like vitamins or herbal remedies?

Official drug interaction warnings state that co-administration with other supplements containing calcium or Vitamin D analogues is restricted due to the documented risk of developing high calcium levels (hypercalcemia). Caution and consultation with a healthcare professional are advised regarding other concurrent supplements, as official information may be limited.

Q: Is the list of side effects in the official documents complete?

The official documentation lists side effects according to their frequency in clinical studies. Some potential effects are classified as 'Not Known' because their frequency cannot be reliably estimated from current data. This regulatory classification acknowledges that the list may not capture every possible or newly identified reaction.

Q: Why is the mechanism of action for Decal described in simple terms?

Regulatory patient information is purposefully written to clearly communicate the drug's basic action to the user. The simple explanation, that Colecalciferol (Vitamin D3) helps the body absorb the Calcium Phosphate, is intended to ensure patients understand the core functional principle without requiring complex chemical or pharmacological knowledge.

Q: Can men and women use Decal for the same condition?

Official indications for use are determined by a documented deficiency or metabolic need for calcium and/or Vitamin D, not by gender. While historical research often focuses on certain high-risk groups, such as postmenopausal women, the general indication for deficiency applies to both men and women.

Q: What is the risk of a serious side effect with Decal?

The risk of a serious side effect is explicitly highlighted in the Warnings and Precautions section of the official label. This includes effects such as an irregular heartbeat resulting from severe high calcium levels (hypercalcemia). Although these events are generally classified as rare or very rare, the potential for them requires a specific warning in the regulatory documentation.

Q: How important is it to read the 'Interactions' section for Decal?

The Interactions section documents serious and clinically significant risks. It includes the documented risk of hypercalcemia when used with other Vitamin D metabolites, and notes potential risks, such as increased risk of cardiac arrhythmias, when used with certain heart medicines.

Q: Does Decal's effectiveness change over time?

Official research summaries note that clinical studies often have limited follow-up durations for the biochemical analysis of effects. This means that long-term evidence regarding the sustained normalization of mineral levels over many years is not currently fully established in regulatory data.

Q: Does Decal cause weight gain or weight loss?

Weight loss is listed as a potential symptom of metabolic adverse reactions related to excessive Vitamin D in the body, a condition known as Hypervitaminosis D. Official warnings note that weight loss may be associated with high levels of the active ingredients.

Q: Can Decal be taken with over-the-counter pain relievers like ibuprofen?

Official documentation does not list a specific drug interaction between Decal and common over-the-counter pain relievers such as non-steroidal anti-inflammatory drugs (NSAIDs). Official sources generally advise individuals to consult a health professional regarding concurrent use of any medicines or supplements.

Q: I heard Decal can affect sleep; is this true?

Official documentation does not specifically list sleep disturbance as a side effect. However, high levels of calcium (Hypercalcemia) can cause central nervous system symptoms such as confusion and tiredness, which may indirectly affect a patient's sleep pattern.

Q: Can Decal cause headaches, and if so, how common is it?

Headache is listed in regulatory summaries as a common side effect associated with this product class. Additionally, headache is a documented symptom of high blood calcium levels (Hypercalcemia), which may be a sign of toxicity.

Q: Can Decal affect my ability to drive or operate machinery?

Official documentation does not issue a direct warning against driving. However, side effects related to high calcium levels, such as tiredness and confusion, may potentially impair a person's ability to drive or safely operate machinery.

Q: How long does Decal stay in your system after you stop taking it?

Official pharmacological data indicates that the effects of Colecalciferol (Vitamin D3), one of the active ingredients, can persist for two or more months after treatment has been discontinued. This persistence in the system is a factor for which patient monitoring is typically advised even after discontinuation.

Q: Can people with high blood pressure use Decal?

Official documentation does not list high blood pressure as a restriction on its own. However, a clinically significant interaction is documented if Decal is used concurrently with Thiazide Diuretics, which are common high blood pressure medicines, as this may lead to dangerously high blood calcium levels.

Q: I saw a forum post about Decal and metal taste, is this a known side effect?

Yes, official adverse reaction summaries list a metallic taste as a potential effect. This is often associated with early symptoms of excessive Vitamin D in the body, a condition known as Hypervitaminosis D.

Q: Are there any lifestyle changes that make Decal work better?

The official label notes that for the medicine to achieve an adequate clinical response, the patient must maintain an adequate dietary calcium intake. For younger patients, a health professional may recommend specific dietary changes to help improve Vitamin D levels.

Q: Are there any warnings about Decal for people with a history of certain mental health conditions?

While specific mental health conditions are not listed as a restriction, official warnings note that severe, rare cases of overdose resulting in high calcium levels may include central nervous system (CNS) effects such as confusion or mental retardation.

How should Decal be stored and disposed of?

How to Store and Dispose of Decal

Official labeling mandates specific conditions to maintain the stability of Decal (Calcium Phosphate and Colecalciferol).


Storage Conditions

Store the medicine at room temperature, typically between 20 C and 25 C (68 F and 77 F). The product must be stored in its original container and kept tightly closed to protect it from excess heat, moisture, and light. To comply with safety regulations, it is mandatory to keep the medicine out of the sight and reach of children.


Disposal Instructions

Unused or expired Decal must be disposed of according to local regulations. The preferred method is using a drug take-back program. If a program is unavailable, mix the medication with an unappealing substance, place it in a sealed bag, and discard it in the household trash. Do not flush the medication down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Decal found in:

A-Z Index: